Micro-3D printing powers cancer organoid research
John Kawola, CEO of micro-3D printing company BMF, explores the role of 3D printing in organoid and cancer research
John Kawola, CEO of micro-3D printing company BMF, explores the role of 3D printing in organoid and cancer research
Supported by 50 years of spectroscopy expertise, this subdivision aims to "deliver accuracy, consistency, and insight"
This next-generation in LC-mass detection is setting new standards for intelligent mass detection, sensitivity, and sustainability
Enabling functional proteoform sequencing and post-translational modification (PTM) identification and localization with unprecedented depth and speed
GutID is the first microbiome test able to identify all bacteria in the gut at the strain level and could help manage and prevent a wide range of diseases
Offering up to 50% improved peptide sensitivity, this technology further enhances robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows
Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class
Rob Walton, CEO of SPT Labtech, shares how a customer-centric approach is shaping the next generation of life science research and inspiring ingenuity